China Health EBITDA
Was ist das EBITDA von China Health?
EBITDA von China Health Group Inc. ist ¥33.415M
Was ist die Definition von EBITDA?
Das EBITDA ist das Ergebnis eines Unternehmens vor Zinsen, Steuern, Abschreibungen und Amortisationen und ist eine Buchhaltungsgröße, die anhand des Nettoergebnisses eines Unternehmens berechnet wird, bevor Zinsaufwendungen, Steuern, Abschreibungen und Amortisationen abgezogen werden, um die derzeitige operative Ertragskraft eines Unternehmens zu ermitteln.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA von Unternehmen in Health Care Sektor auf HKSE im Vergleich zu China Health
Was macht China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Unternehmen mit ebitda ähnlich China Health
- Select Harvests hat EBITDA von AUD$33.210M
- The Tra.Desk A Dl ,000001 hat EBITDA von $33.264M
- Gascogne SA hat EBITDA von €33.269M
- Brooks MacDonald Plc hat EBITDA von £33.312M
- LHN hat EBITDA von SGD$33.325M
- CTI Logistics hat EBITDA von AUD$33.366M
- China Health hat EBITDA von ¥33.415M
- Ortel Communications hat EBITDA von ₨33.460M
- Prajay Engineers Syndicate hat EBITDA von ₨33.507M
- Monash IVF hat EBITDA von AUD$33.513M
- Madhav Marbles and Granites hat EBITDA von ₨33.514M
- Revolve Inc hat EBITDA von $33.546M
- Prairie Provident Resources hat EBITDA von CAD$33.675M